Validating chemoimmunotherapy in small-cell lung cancer

Lancet Oncol. 2022 Jun;23(6):692-693. doi: 10.1016/S1470-2045(22)00288-1. Epub 2022 May 13.

Authors

Katherine E R Smith¹, Aaron S Mansfield²

Affiliations

¹ Division of Medical Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
² Division of Medical Oncology, Mayo Clinic, Rochester, MN, 55905, USA. Electronic address: mansfield.aaron@mayo.edu.

PMID: 35576958
DOI: 10.1016/S1470-2045(22)00288-1

No abstract available

Publication types

Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung* / drug therapy
Humans
Immunotherapy / adverse effects
Lung Neoplasms* / drug therapy
Small Cell Lung Carcinoma* / drug therapy